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1032-130 Dobutamine-Induced Obstruction May Not Predict 
Exercise-Induced Obstruction in Hypertrophic 
Cardiomyopathy
Donogh F. McKeogh, Crispin H. Davies, Oregon Health & Science University, Portland, 
OR
Background: Alcohol septal ablation is increasingly used for the treatment of exertional
dyspnea in patients with hypertrophic cardiomyopathy with obstruction (HOCM). The
dobutamine (D)-provoked LV outflow pressure gradient (PG) is commonly used to deter-
mine which patients with HOCM should undergo the procedure.
Methods: To determine the clinical relevance of D-PG, we performed echocardiography
during both D infusion and incremental upright bicycle exercise (Ex) in 10 consecutive
HOCM patients referred for alcohol septal ablation.
Results: Mean age was 52 years, maximal D dose was 9.4 mcg/Kg/min, and maximal tol-
erated workload was 101 Watts. Mean data are as shown: 
* p < 0.05, ** p < 0.01, compared to D value
As compared with D, the average percentage increase in PG was much less with Ex 
(117% vs 326%) despite much greater increases in heart rate (HR) (74% vs 28%) and 
systolic blood pressure (SBP) (25% vs 8%). During Ex, patients achieved a much higher 
double product (20,147 vs. 10,123, p < 0.001) at a lower PG (73 vs. 104 mmHg, p < 
0.01). Patients reported that the level of exertion during testing exceeded that encoun-
tered in daily life, and their measured exercise capacity was greater than expected from 
reported NYHA class: 1.7 vs. 2.5 (p <0.05).
Conclusion: D-induced gradients are of uncertain clinical relevance in HOCM. When 
alcohol septal ablation is being considered exercise testing may be preferable to deter-
mine if a provocable PG is likely to contribute to a patient’s exertional dyspnea.
1032-131 Impaired Coronary Circulation in Patients With Apical 
Hypertrophic Cardiomyopathy: Noninvasive Analysis by 
Transthoracic Doppler Echocardiography
Ken Yoshida, Takeshi Hozumi, Yasuhiko Takemoto, Kenichi Sugioka, Hiroyuki Watanabe, 
Minoru Yoshiyama, Kazuhide Takeuchi, Junichi Yoshikawa, Osaka City University 
Medical School, Osaka, Japan
Background: Abnormal coronary flow and coronary flow reserve have been identified in
patients with hypertrophic cardiomyopathy (HCM). However, characteristics of coronary
circulation in patients with apical hypertrophic cardiomyopathy (ApHCM), that is a rela-
tively rare form of HCM, have not been fully assessed. Recent advancement in transtho-
racic Doppler echocardiography (TTDE) provides noninvasive assessment of coronary
flow velocity (CFV) pattern and reserve (CFVR) with coronary vasodilators in patients
with various cardiac diseases. Thus, we designed this study to examine the characteris-
tics of CFV and CFVR in patients with ApHCM. Methods: We analyzed the wall thickness
of apical hypertrophied myocardium and basal posterior wall, and CFV and CFVR in the
distal portion of the left anterior descending coronary artery (LAD) in 10 patients with
ApHCM (63 +/- 6 years) and 10 control subjects (61 +/- 6 years). The apical to posterior
wall ratio (AW/PW) and the characteristics of following CFV parameters at rest and dur-
ing hyperemia (intravenous ATP: 0.14mg/kg per minute) were measured; mean diastolic
velocity (MDV), time from beginning of diastole to peak velocity corrected by squared RR
interval (TPV), and CFVR defined as a ratio of hyperemic MDV to MDV at rest. Results: A
higher AW/PW and MDV, and a longer TPV were observed in ApHCM than those of con-
trol subjects at rest (1.7 +/- 0.1 versus 0.7 +/- 0.1, and 29 +/- 6 versus 17 +/- 5 cm/sec,
and 5.2 +/- 1.0 versus 3.4 +/- 0.6 msec; p< 0.01, respectively). CFVR in ApHCM was sig-
nificantly lower compared with in control subjects (1.8 +/- 0.4 versus 2.9 +/- 0.7; p<0.01),
whereas MDV during hyperemia was similar between ApHCM and control subjects (53 +/
- 13 versus 54 +/- 21 cm/sec). CFVR and MDV at rest in ApHCM showed significant cor-
relations with AW/PW in the left ventricle (AW/PW=0.51*CFVR + 4.29; r=-0.84; p<0.01,
and AW/PW=0.51*MDV + 2.48; r=0.74; p<0.05, respectively). Conclusion: CFV analysis
by TTDE revealed that coronary circulation in the LAD was impaired in ApHCM because
of increased resting coronary flow related to localized hypertrophy in the apical myocar-
dium.
1032-132 An Analysis of Patients With Hypertrophic Obstructive 
Cardiomyopathy and Persisting New York Heart 
Association Class III Symptoms During Long-Term 
Follow-Up After Septal Ablation
Dirk Welge, Lothar Faber, Hubert Seggewiss, Dieter Fassbender, Dieter Horstkotte, 
Heart Center North Rhine-Westphalia, Bad Oeynhausen, Germany, Leopoldina Hospital, 
Schweinfurt, Germany
Background and introduction: In about 90% of the patients (pts). with symptomatic hyper-
trophic obstructive cardiomyopathy (HOCM), symptoms and outflow gradient (LVOTG)
can significantly be reduced by septal ablation (PTSMA). Pts. with persisting heart failure
symptoms during long-term follow-up after PTSMA are not characterized sufficiently. We
analyzed our long-term cohort of 178 pts. treated between 1996 and 1998 with respect to
persisting or recurrent NYHA functional class III symptoms.
Results: Hospital mortality was 1.7% (VF, pulmonary embolism, and pericardial tampon-
ade in 1 pt. each). Mean CK rise was 599±300 U/l. A DDD-pacemaker (DDD-PM) had to
be implanted in 13 pts. (7%). Mean follow-up time is now 55±15 months, 8 pts. (5%) were
lost to follow-up. Out of the 167 cases analyzed, 12 pts. (7%) underwent a re-PTSMA and
4 (2%) a myectomy. These cases included, 156 pts. (88%) had complete elimination of
obstruction, and151 pts. (85%) reported sustained symptomatic improvement at their last
follow-up.
Persisting or recurrent class III symptoms, however, were reported by 16 pts. (10%).
LVOTG recurrence or persistence was the suspected reason in only 2 of these cases, 8
pts. were free from LVOT obstruction, and 6 had provocable gradients <60 mm Hg con-
sidered hemodynamically irrelevant. The leading reason for persisting class III symptoms
despite satisfactory LVOTG reduction were marked obesity (BMI>30/m2) in 5, severe
diastolic LV dysfunction in 5, and coexistent pulmonary disease in 4 pts. 9 pts. (5%) died
during long-term follow-up: due to stroke (n=3), extracardiac disease (n=3), or suspected
sudden cardiac death (n=3).
Conclusions: PTSMA results in a persistent LVOTG reduction and symptomatic improve-
ment during long-term follow up. Peri-interventional and long-term mortality seem to be
at least comparable to surgical myectomy. Pts. with marked obesity, coexistent pulmo-
nary disease, and advanced diastolic LV dysfunction are less likely to have symptomatic
benefit from LVOTG reduction, and need additional treatment of these abnormalities.
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1033-109 Assessing the Need for Repeat Baseline Exercise Tests 
in Heart Failure Patients: Early Experience From HF-
ACTION
Daniel R. Bensimhon, Stephen J. Ellis, Steven J. Keteyian, Ileana L. Pena, Dalane W. 
Kitzman, William E. Kraus, Lawton S. Cooper, Robin Boineau, Jerome L. Fleg, Robert S. 
McKelvie, Eric Leifer, Andrew Kao, David J. Whellan, Christopher M. O'Connor, Stuart D. 
Russell, for the HF-ACTION Investigators, Duke Clinical Research Institue, Durham, NC, 
Duke University Medical Center, Durham, NC
Background: Aerobic capacity is an important outcome in heart failure trials and is often
quantified by expired gas analysis during exercise testing. However, patient familiariza-
tion can lead to improvements in exercise parameters over serial testing. Thus, many tri-
als require multiple baseline tests. In clinical practice, however, a single test is routinely
used for prognosis or exercise prescription.
HF-ACTION is a multi-center randomized controlled trial designed to evaluate the effect
of exercise training on morbidity and mortality in 3,000 patients with an ejection fraction <
35% and NYHA class II-IV symptoms. The protocol specifies that two cardiopulmonary
exercise tests (CPXs) be conducted at baseline. After the first 100 subjects, an analysis
was planned to determine if multiple baseline tests are necessary; the results are
reported here.
Methods: Each subject underwent two maximal CPXs using a Modified Naughton proto-
col. Baseline tests were separated by > 48 hours but < seven days. Exercise time, VO2,
heart rate (HR), respiratory exchange ratio (RER), and rating of perceived exertion (RPE)
were measured. Quality control included investigator training, submission of sample
tests, and oversight by a core lab.
Results: n=85
Conclusion: With appropriate quality control, serial baseline exercise tests do not result 
in improvements in HRR or maximum aerobic capacity. Therefore, when peak VO2 and 
HRR are used as outcome measures or for exercise prescription, only a single baseline 
test is needed.
1033-110 Lowered Resting Heart Rate in High Fit Healthy 
Subjects Is Caused by a Lowered Intrinsic Heart Rate, 
Not by Elevated Parasympathetic Tone
Marianne Bootsma, Cees A. Swenne, Liming Han, Martin J. Schalij, Ernst E. Van der 
Wall, Leiden University Medical Center, Leiden, The Netherlands
Background. High fit subjects have a lower resting heart rate than low fit subjects.
Whether this is caused by an altered resting sympathetic or parasympathetic tone or by
an altered intrinsic heart rate is still a matter of debate.
Methods. We studied 21 low fit (VO2max 39.8 ± 6.3 ml×kg-1×min-1) and 23 high fit
(VO2max 57.6 ± 5.5 ml×kg-1×min-1) healthy young male subjects. Adopting the Rosen-
blueth-Simeone model for autonomic heart rate modulation, HR=m•n•IHR, we measured
resting heart rate (HR) and, with two-stage complete pharmacological autonomic block-
Resting HR Peak HR SBP rest (mmHg) SBP max
(mmHg)
PG rest
(mmHg)
PG max
(mmHg)
D 64 82 114 124 34 104
Ex 74* 126** 127 158* 42 73**
mean
T1
mean
T2
SD of 
(T2-T1)
% of 
tests
T2>T1
% of
tests 
T1>T2
p-value
(t-test)
Exercise time (secs) 599 626 83.6 65 31 0.003*
Peak VO2 (ml/kg/min) 14.84 14.92 1.99 55 37 0.71
Peak RER 1.11 1.12 0.08 63 33 0.33
Peak HR (bpm) 120 121 10.44 55 38 0.36
Peak RPE (Borg) 17.2 17.6 1.63 45 19 0.021*
Training HR based on 60% 
heart rate reserve (HRR) (bpm)
100.1 101.1 8.33 55 45 0.28
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ade by metoprolol and atropine, intrinsic heart rate (IHR) and the factors m (sympathetic
tone) and n (vagal tone). To compare our results with those of other studies who used
heart rate variability (HRV) to indirectly assess autonomic tone, we also measured a
standard set of time domain (SDNN, CV, pNN50) and frequency domain (VLF, LF, HF)
HRV parameters preceding autonomic blockade.
Results. HR, IHR and all HRV parameters in the low and high fit group differed signifi-
cantly (P<0.05). However sympathetic tone (m) and vagal tone (n) were not significantly
different. See Table. 
Conclusions. Our HRV findings are comparable with those of other groups, who then 
usually conclude that there are autonomic differences between the low and high fit 
groups. Our direct pharmacological assessment of autonomic tone shows that such a 
conclusion is incorrect: the difference in resting heart rate between the low and high fit 
groups is caused by a difference in intrinsic heart rate.
1033-111 Influence of Heart Failure Etiology on the Prognostic 
Value of Peak Oxygen Consumption and the Minute 
Ventilation-Carbon Dioxide Production Slope
Ross Arena, Jonathan Myers, Syed Salman Aslam, Elsa Varughese, Mary Ann Peberdy, 
Virginia Commonwealth University, Richmond, VA, VA Palo Alto Health Care System, 
Palo Alto, CA
Background: Ventilatory expired gas analysis consistently demonstrates prognostic sig-
nificance in the heart failure (HF) population. Peak oxygen consumption (VO2) and the
minute ventilation-carbon dioxide production (VE/VCO2) slope are viewed as holding the
most prognostic value. While the literature establishing their prognostic value is robust,
little has been done to examine the impact of HF etiology. The present study investigates
the effect of HF etiology on these prognostic markers.
Methods: 235 subjects underwent exercise testing with ventilatory expired gas analysis.
The overall group was divided into ischemic (110 male/17 female) and non-ischemic (94
male/14 female) groups and tracked for the occurrence of cardiac-related events for one
year post testing.
Results: Age (61.4 vs. 52.9) was significantly higher and peak VO2 (15.3 vs. 17.9 ml•kg-
1•min-1) was significantly lower in the ischemic group (p<0.01). VE/VCO2 slope (33.8-
ischemic vs. 32.0-non-ischemic) and ejection fraction (32.6%-ischemic vs. 31.6%-non-
ischemic) were similar (p>0.05). The ischemic and non-ischemic groups had 44 (39 hos-
pitalizations/5 deaths) and 26 (23 hospitalizations/3 deaths) cardiac-related events.
Univariate Cox regression found the ability of peak VO2 and VE/VCO2 slope to predict
events was significant in both the ischemic (peak VO2: Chi-square = 19.1, VE/VCO2
slope: Chi-square = 20.4, p<0.001) and non-ischemic (peak VO2: Chi-square = 12.9, VE/
VCO2 slope: Chi-square = 59.4, p<0.001) groups. Multivariate Cox regression revealed
peak VO2 added significant predictive value to VE/VCO2 slope in the ischemic (Residual
Chi-square = 6.6, p=0.01) but not the non-ischemic (Residual Chi-square = 0.15, p=0.70)
group. A post hoc analysis found age was not a significant predictor of events (Chi-
square = 0.07, p=0.80).
Conclusion: HF etiology appears to influence the prognostic characteristics of well-
established ventilatory expired gas variables. Although age was significantly different
between groups, it did not predict adverse events. Development of different, etiology
based, prognostic classification schemes may be warranted when analyzing ventilatory
expired gas data in clinical practice.
1033-112 Impaired Right Ventricular Systolic Function Following 
Completion of Prolonged Strenuous Exertion
Malissa J. Wood, Danita M. Yoerger, Marielle Scherrer-Crosbie, Genevieve A. 
Derumeaux, Pamela S. Douglas, Jane E. Marshall, Arthur E. Weyman, Michael H. 
Picard, Massachusetts General Hospital, Boston, MA
Background: Prolonged endurance exercise leads to decreased global left ventricular
contractility, but right ventricular (RV) contractile function has not been assessed. We
sought to determine if subtle changes in RV function could be detected after strenuous
exercise using less load-dependent indices including strain(S)/strain rate(SR).
Methods: Baseline TTE was performed <3 weeks before (pre) and at the finish line after
(post) the 2003 Boston Marathon in 14 runners. TTE included 2-D, spectral and color
Doppler myocardial imaging. Pre and post RV areas (systole/diastole) were measured
and RV area change calculated. Longitudinal myocardial deformation (peak systolic
strain (S) and strain rate (SR)) was measured in the basal, mid and apical segments of
the RV free wall. Results: 8 males and 6 females with a mean age of 34.8+/-9.5 yrs had
a mean change in weight of – 1.1+/-2.1 kg. Mean heart rate increased from 68+/-13 bpm
to 89.5+/-15 bpm (p<0.00001). No significant changes in RV areas were observed. Base-
line RV S and SR were highest in the apex and both decreased significantly after strenu-
ous exercise. Conclusions: Despite an increase in heart rate (known to increase S and
SR) and an absence of significant RV area change, our subjects exhibited decreased
contractile function in the RV by strain rate imaging. This change was most pronounced
in the RV apex which exhibits the greatest degree of longitudinal deformation at baseline.
1033-113 Correlation of Abnormal Heart Rate Recovery 
Immediately After Exercise With Risk Markers Obtained 
From Exercise Treadmill Test and Myocardial Perfusion 
SPECT
Adriana J. Soares, Andrea De Lorenzo, Ronaldo S. L. Lima, Federal University of Rio de 
Janeiro, Rio de Janeiro, Brazil, Cintilab, Rio de Janeiro, Brazil
Background: Many types of markers have been described to identify high cardiovascular
risk. Among them, those obtained from myocardial perfusion single-photon emission
computed tomography (SPECT) have been shown to provide relevant prognostic infor-
mation. Recent studies have demonstrated a strong correlation between abnormal heart
rate recovery (HRR) at 1 minute after exercise (< 12 beats) and high mortality. This study
sought to verify the correlation between HRR at 1 minute after exercise treadmill test
(ETT) and other indicators of risk for cardiovascular events obtained from ETT and myo-
cardial perfusion SPECT. Methods: 2,189 patients (1,294 males, age 56.7 ± 10.5 years)
who underwent exercise/rest Tc-99m sestamibi myocardial perfusion SPECT were pro-
spectively enrolled; those taking beta-blockers or calcium-channel antagonists were
excluded. ETT was performed according to a symptom-limited Bruce protocol. HRR at 1
minute was obtained from the subtraction of the heart rate (HR) in the first minute of
recovery after exercise from maximal HR during exercise. Myocardial perfusion SPECT
was semiquantitatively analyzed using a 17-segment left ventricular model. Results: 13%
of patients had abnormal HRR at 1 minute after exercise. Patients with abnormal HRR
had higher resting HR and blood pressure, shorter exercise duration, were more fre-
quently unable to reach 85% of maximal predicted HR (chronotropic incompetence, CI)
and had higher perfusion defect quantification scores than patients with normal HRR.
Multivariate analysis identified age (p<0.0001), resting HR (p<0.0001), CI (p<0.005),
exercise duration (p<0.0001), and perfusion defect extent and severity at rest (p=0.01) as
independent predictors of abnormal HRR at 1 minute after exercise. Conclusion: Abnor-
mal HRR was significantly associated with known exercise and SPECT indicators of risk.
Interestingly, it was associated with perfusion defect extent and severity at rest, but not
with SPECT indices of myocardial ischemia. Therefore, abnormal HRR may be a marker
of myocardial damage.
1033-114 T-Wave Alternans Is Associated With Spatial 
Heterogeneity of T-Wave Morphology in Coronary Artery 
Disease Patients During Treadmill Exercise
Bruce D. Nearing, Peter H. Stone, Jason Cole, Richard L. Verrier, The Vascular Basis 
Study Group, Beth Israel Deaconess Medical Center, Boston, MA, Brigham & Women's 
Hospital, Boston, MA
BACKGROUND: The electrophysiologic basis for exercise-stress induced T-wave altern-
ans (TWA) in human subjects is not well understood. We postulated that TWA during
exercise treadmill testing (ETT) reflects increased spatial heterogeneity of repolarization.
METHODS: Normal volunteers (16) and stable coronary artery disease (CAD) patients
(16) were evaluated who were enrolled in the Vascular Basis study, a multicenter clinical
trial investigating the effects of lipid-lowering therapy on myocardial ischemia. Patients
were withdrawn from all anti-anginal medications for 2 days prior to performing a stan-
dard ETT (ACIP protocol). Precordial electrocardiograms (ECGs) were recorded with
standard electrodes, digitized at 500 Hz, filtered at 50 Hz, and baseline wander artifact
was removed. The time-domain Modified Moving Average analysis method, which pre-
dicts cardiac arrest or arrhythmic death in post-myocardial infarction patients on ambula-
tory ECG, was used to measure TWA. Spatial T-wave heterogeneity (TWH) was
determined by second central moment analysis of T-wave morphology. This recently pub-
lished technique computes the interlead variance in morphology over the entire T-wave
and circumvents difficulties associated with protracted or indistinct termination of the T
wave, which can be problematic in conventional QT dispersion measurement. TWA and
TWH levels were assessed at 120 bpm.
RESULTS: Baseline TWA and TWH values did not differ between the CAD patients and
normal volunteers. In CAD patients, TWA increased by 444% (from baseline 11.35±0.98
to 61.69±6.28µV, p<0.001) during ETT. In normal subjects, TWA increased by only 139%
(from baseline 14.46±1.15 to 34.54±2.95µV, p<0.001). ETT-induced TWA levels were
higher in CAD patients than normals (p<0.001). Concomitantly, TWH increased by 68%
(from 86.42±13.80 to 117.73±16.51µV) in CAD patients as compared to only 20% (from
77.29±14.14 to 84.21±13.46µV) in normals (p<0.05). CONCLUSION: Exercise-induced
TWA in CAD patients reflects significant levels of spatial heterogeneity of repolarization,
which may underlie the predictive utility of TWA in estimating risk of sudden cardiac
death.
Low fit (N=21) High fit (N=23)
HR (bpm) 62.5 ± 10.9* 56.2 ± 6.5
IHR (bpm) 92.8 ± 9.9* 85.2 ± 7.1
m 1.15 ± 0.07 1.15 ± 0.03
n 0.59 ± 0.08 0.58 ± 0.05
SDNN (s) 0.08 ± 0.03* 0.11 ± 0.03
CV (%) 7.51 ± 2.08* 10.15 ± 2.68
pNN50 (%) 28.5 ± 21.4* 44.7 ± 16.2
VLF (*10-3) 1.79 ± 0.97* 3.25 ± 2.18
LF (*10-3) 2.03 ± 1.38* 3.07 ± 1.76
HF (*10-3) 1.33 ± 1.10* 2.85 ± 2.58
Pre Post P-value
RV Basal S -19.45±4.4 -17.6±5.6 0.48
RV Mid S -24.44±3.61 -24.34±3.94 0.73
RV Apical S -32.8±4.0 -27.29±4.11 0.0013
RV Basal SR -1.36±0.5 -1.19±0.42 0.51
RV Mid SR -1.5±0.38 -1.4±0.79 0.98
RV Apical SR -2.32±0.71 -1.79±0.87 0.04
